What is the clinical relevance of erosions and joint space narrowing in RA?

[1]  Matthias Schneider,et al.  Molecular imaging of cartilage damage of finger joints in early rheumatoid arthritis with delayed gadolinium-enhanced magnetic resonance imaging. , 2012, Arthritis and rheumatism.

[2]  H. Genant,et al.  Development and Preliminary Validation of a Magnetic Resonance Imaging Joint Space Narrowing Score for Use in Rheumatoid Arthritis: Potential Adjunct to the OMERACT RA MRI Scoring System , 2011, The Journal of Rheumatology.

[3]  D. M. van der Heijde,et al.  Joint space narrowing, cartilage and physical function: are we deceived by measurements and distributions? , 2011, Annals of the rheumatic diseases.

[4]  D. M. van der Heijde.  Erosions versus joint space narrowing in rheumatoid arthritis: what do we know? , 2011, Annals of the rheumatic diseases.

[5]  J. Smolen,et al.  Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction , 2011, Annals of the rheumatic diseases.

[6]  J. Sharp,et al.  Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials , 2009, Annals of the rheumatic diseases.

[7]  J. Smolen,et al.  Does damage cause inflammation? Revisiting the link between joint damage and inflammation , 2009, Annals of the rheumatic diseases.

[8]  Susanne Juhl Pedersen,et al.  Imaging in rheumatoid arthritis--status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. , 2008, Best practice & research. Clinical rheumatology.

[9]  D. M. van der Heijde,et al.  Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing , 2008, Annals of the rheumatic diseases.

[10]  D. M. van der Heijde,et al.  Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade , 2008, Annals of the rheumatic diseases.

[11]  J. Loge,et al.  Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data. , 2007, Arthritis and rheumatism.

[12]  D. M. van der Heijde,et al.  Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial , 2007, Annals of the rheumatic diseases.

[13]  Tanja Stamm,et al.  Reliability of the ICF Core Set for rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[14]  Michael M Ward,et al.  Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components. , 2006, Arthritis and rheumatism.

[15]  D. M. van der Heijde,et al.  Measurement of joint space width and erosion size. , 2005, The Journal of rheumatology.

[16]  D. M. van der Heijde,et al.  Presentation and analysis of radiographic data in clinical trials and observational studies , 2005, Annals of the rheumatic diseases.

[17]  H. Paulus,et al.  Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage. , 2005, Arthritis and rheumatism.

[18]  L. Klareskog,et al.  Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial , 2004, The Lancet.

[19]  Bonnie Bruce,et al.  The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications , 2003, Health and quality of life outcomes.

[20]  Paul Bird,et al.  OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. , 2003, The Journal of rheumatology.

[21]  D. Heijde,et al.  Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment? , 2001, Annals of the rheumatic diseases.

[22]  F Guillemin,et al.  Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. , 2001, Annals of the rheumatic diseases.

[23]  L. Kiemeney,et al.  The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[24]  A Woolf,et al.  The links between joint damage and disability in rheumatoid arthritis. , 2000, Rheumatology.

[25]  D. M. van der Heijde,et al.  Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. , 1999, Rheumatology.

[26]  F. Miese.  Cartilage damage in early rheumatoid arthritis: biochemical MRI of finger cartilage with the dGEMRIC method (delayed Gd(DTPA)2- enhanced MRI of cartilage) , 2012 .

[27]  V. Ravindran,et al.  An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials , 2010, Clinical Rheumatology.

[28]  Maurizio Cutolo,et al.  Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.

[29]  D. M. van der Heijde,et al.  Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. , 2006, Arthritis and rheumatism.

[30]  L. V. D. Putte,et al.  Patients with rheumatoid arthritis in clinical care , 2004 .

[31]  L. Kazis,et al.  AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. , 1992, Arthritis and rheumatism.

[32]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[33]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.